Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Long-term U.S. clinical trial results for orlistat reported in Stockholm

Sep. 3, 1997

Pfizer identifies potent cholesterol absorption inhibitors

Sep. 3, 1997

Crinone launched in the U.S.

Sep. 3, 1997

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

Aug. 29, 1997

Review of fenfluramines points to neurotoxicity

Aug. 29, 1997

FDA wants stronger warning labels for fen/phen

Aug. 29, 1997

First regulatory submission filed for Macritonin

Aug. 28, 1997

CURVES study results point in favor of atorvastatin

Aug. 28, 1997

FDA approves nonsurgical treatment for BPH

Aug. 28, 1997

Roche withdraws NDA for orlistat

Aug. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...